Intrinsic Value of S&P & Nasdaq Contact Us

Vera Therapeutics, Inc. VERA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$77.60
+74.9%

Stock Statistics — VERA

Vera Therapeutics, Inc. (VERA) has a market capitalization of $3.17B and trades at $44.36. The 52-week range is 18.53-56.05.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.5, Earnings Per Share (EPS) of $-4.66.

The stock has a beta of 1.17, operates in the Healthcare sector.

Trading Data
Current Price$44.36
52-Week Range18.53-56.05
Volume1.23M
Avg Volume (30D)1.42M
Market Cap$3.17B
Beta (1Y)1.17
Company
IPO Date2021-05-14
Employees152
CEOMarshall W. Fordyce
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS92337R1014
CUSIP92337R101
Income (Latest Year)
Gross Profit$-468K
EBITDA$-291.62M
Operating Income$-315.47M
Net Income$-299.62M
EPS$-4.66
EPS Diluted$-4.66
Shares Outstanding$64.23M
Balance Sheet (Latest Year)
Total Assets$734.73M
Current Assets$728.88M
Cash & ST Investments$714.59M
Total Liabilities$130.21M
Total Debt$77.31M
Net Debt$-277.42M
Total Equity$604.52M
Debt / Equity0.13
Valuation Ratios
P/E Ratio-9.5
P/B Ratio5.24
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message